‘Imminent’ Generic Approvals Expected To Help US FDA Meet On-Time Review Metric Retroactively

 
• By Derrick Gingery
  
Generic drug pills
The falling on-time action rate for generic drug applications could be a concern for sponsors. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards